People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ceptur Therapeutics, Inc. | — | Biotechnology | Series B | $27.7M | $453.2M | 2020 |
Samuel Gunderson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Samuel Gunderson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paiman Peter Ghoroghchian | 1 | 2 |
| Daniel I. Heller | 1 | 1 |
| Aaron I. Kantoff | 1 | 1 |
| D. James Ballance | 1 | 1 |
| Rafal Goraczniak | 1 | 1 |
| Cynthia James Davis | 1 | 1 |
| Samuel I. Gunderson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.